Search Ontology:
ChEBI
suvorexant
- Term ID
- CHEBI:82698
- Synonyms
-
- [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone
- BELSOMRA
- MK 4305
- MK-4305
- MK4305
- suvorexant
- Definition
- An aromatic amide obtained by formal condensation of the carboxy group of 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid with the secondary amino group of 5-chloro-2-[(5R)-5-methyl-1,4-diazepan-1-yl]-1,3-benzoxazole. An orexin receptor antagonist used for the management of insomnia.
- References
-
- CAS:1030377-33-3
- Drug_Central:4881
- KEGG:D10082
- PMID:23372274
- PMID:23692283
- PMID:24368893
- PMID:24488306
- PMID:24550770
- PMID:24680372
- PMID:24757363
- PMID:25167596
- PMID:25197807
- PMID:25227290
- PMID:25231363
- PMID:25291725
- PMID:25299902
- Reaxys:18339082
- Wikipedia:Suvorexant
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from suvorexant
Phenotype where environments contain suvorexant
Phenotype modified by environments containing suvorexant
Human Disease Model